Asunción Morán Selected Research

1- (2- (4- (4- fluoro- benzoyl)- piperidin- 1- yl)- ethyl)- 3,3- dimethyl- 1,2- dihydro- indol- 2- one

5/2022

Fluoxetine Treatment Decreases Cardiac Vagal Input and Alters the Serotonergic Modulation of the Parasympathetic Outflow in Diabetic Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Asunción Morán Research Topics

Disease

7	Bradycardia 05/2022 - 11/2007
2	Body Weight (Weight, Body) 09/2022 - 03/2022
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2022 - 03/2022
2	Hypertension (High Blood Pressure) 01/2019 - 10/2009
2	Alzheimer Disease (Alzheimer's Disease) 03/2010 - 01/2010
1	Polyuria 09/2022
1	Polydipsia 09/2022
1	Hyperglycemia 09/2022
1	Diabetes Complications 05/2022
1	Tachycardia (Tachyarrhythmias) 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2019
1	Portal Hypertension 01/2013
1	Fibrosis (Cirrhosis) 01/2013
1	Pick Disease of the Brain (Pick's Disease) 01/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2010

Drug/Important Bio-Agent (IBA)

9	Serotonin (5 Hydroxytryptamine)IBA 09/2022 - 11/2007
4	Acetylcholine (Acetylcholine Chloride)FDA Link 05/2022 - 11/2007
3	Serotonin ReceptorsIBA 09/2022 - 11/2007
3	Fluoxetine (Prozac)FDA LinkGeneric 05/2022 - 02/2019
2	sarpogrelateIBA 09/2022 - 01/2017
2	Antidepressive Agents (Antidepressants)IBA 05/2022 - 02/2019
2	L 694247IBA 05/2022 - 11/2007
2	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2019 - 10/2009
2	Drinking WaterIBA 01/2019 - 10/2009
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 01/2017 - 11/2007
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 01/2010 - 11/2007
2	5-carboxamidotryptamineIBA 01/2010 - 11/2007
2	AlloxanIBA 01/2010 - 11/2007
1	Blood Glucose (Blood Sugar)IBA 09/2022
1	Cholinergic Agents (Cholinergics)IBA 05/2022
1	1- (2- (4- (4- fluoro- benzoyl)- piperidin- 1- yl)- ethyl)- 3,3- dimethyl- 1,2- dihydro- indol- 2- oneIBA 05/2022
1	Urea (Carbamide)FDA LinkGeneric 03/2022
1	NitrogenIBA 03/2022
1	CreatinineIBA 03/2022
1	3- (4- (4- chlorophenyl- 4- hydroxypiperidino)methyl)indoleIBA 12/2020
1	3- ((4- (4- chlorophenyl)piperazin- 1- yl)methyl)- 1H- pyrrolo(2,3- b)pyridineIBA 12/2020
1	QuinpiroleIBA 12/2020
1	SB 277011IBA 12/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2020
1	LY 344864IBA 11/2020
1	indorenate (TR3369)IBA 11/2020
1	arginine methyl esterIBA 01/2019
1	5-HT4 Serotonin ReceptorsIBA 01/2019
1	3,N- dimethyl- N- (1- methyl- 3- (4- methylpiperidin- 1- yl)propyl)benzenesulfonamideIBA 01/2017
1	serotonin 7 receptorIBA 01/2017
1	Histamine (Histamine Dihydrochloride)FDA Link 02/2016
1	methimepipIBA 02/2016
1	Histamine H3 Receptors (Histamine H3 Receptor)IBA 02/2016
1	Propranolol (Inderal)FDA LinkGeneric 01/2013
1	zolmitriptan (Zomig)FDA Link 01/2013
1	Glycogen Synthase Kinase 3IBA 03/2010
1	GTP Phosphohydrolases (GTPases)IBA 01/2010
1	maleic acid (maleate)IBA 01/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2009
1	Arginine (L-Arginine)FDA Link 10/2009
1	alpha-methylserotoninIBA 11/2007
1	CGS 12066BIBA 11/2007
1	5-HT1A Serotonin ReceptorIBA 11/2007
1	5-HT1B Serotonin ReceptorIBA 11/2007
1	5-HT1D Serotonin ReceptorIBA 11/2007
1	mesulergineIBA 11/2007
1	hydroxide ionIBA 11/2007
1	BRL 15572IBA 11/2007
1	phenyl biguanideIBA 11/2007
1	MethiothepinIBA 11/2007

Therapy/Procedure

2	Injections 12/2020 - 02/2016
1	Intravenous Injections 12/2020
1	Ligation 01/2013
1	Therapeutics 01/2013
1	Intravenous Administration 01/2010